Details of the Drug

General Information of Drug (ID: DMOX8E3)

• Drug Name: PMID26882240-Compound-7
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 3:
  Molecular Weight (mw); 543.6
  Logarithm of the Partition Coefficient (xlogp); 5.5
  Rotatable Bond Count (rotbonds); 11
  Hydrogen Bond Donor Count (hbonddonor); 1
  Hydrogen Bond Acceptor Count (hbondacc); 7
• Chemical Identifiers:
  Formula: C32H33NO7
  IUPAC Name: furan-2-ylmethyl 3-[4-[2-(3-methoxycarbonylanilino)-2-oxoethoxy]phenyl]adamantane-1-carboxylate
  Canonical SMILES: COC(=O)C1=CC(=CC=C1)NC(=O)COC2=CC=C(C=C2)C34CC5CC(C3)CC(C5)(C4)C(=O)OCC6=CC=CO6
  InChI: InChI=1S/C32H33NO7/c1-37-29(35)23-4-2-5-25(13-23)33-28(34)19-39-26-9-7-24(8-10-26)31-14-21-12-22(15-31)17-32(16-21,20-31)30(36)40-18-27-6-3-11-38-27/h2-11,13,21-22H,12,14-20H2,1H3,(H,33,34)
  InChIKey: GQISNYKUWPQVDL-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 118364731
  TTD ID: D05MTZ

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hypoxia-inducible factor 1 (HIF-1)	TTUX68I	NOUNIPROTAC	Inhibitor	[1]

References

• [1] Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015).Expert Opin Ther Pat. 2016;26(3):309-22.